SR

Sarita Rajkumar Chawla

Director Additional Director DIN 01602458
DIN 01602458 First appointment Nov 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Sarita Rajkumar Chawla

Data last updated:

Sarita Rajkumar Chawla was an Additional Director at Unibios Laboratories Limited (2006–2010) and Director at Craas Securities Trading Private Limited (from 2011). The companies operate in Pharma.

DIN 01602458
Primary Designation Additional Director
Industry Pharma
First Appointment 01 Nov 2006
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unibios Laboratories Limited U24230MH1991PLC061362
Additional Director01 Nov 20061991Under Liquidation
Director05 Sep 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Craas Securities Trading Private Limited
Unibios Laboratories Limited
Premium access

Shareholding and investment profile for Sarita Rajkumar Chawla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarita Rajkumar Chawla

Sarita Rajkumar Chawla was first appointed on 01 Nov 2006 as Additional Director at Unibios Laboratories Limited. The most recent appointment on record is 05 Sep 2011 at Craas Securities Trading Private Limited.

Sarita Rajkumar Chawla held 2 earlier board appointments: Unibios Laboratories Limited (Additional Director, 01 Nov 2006 to 01 Oct 2010); Craas Securities Trading Private Limited (Director, from 05 Sep 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available